Hillerod, Denmark

Christian Borch Jacobsen

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: H. Lundbeck A/s. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Borch Jacobsen. Retrieved from https://idiyas.com/inventor/christian-borch-jacobsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christian Borch Jacobsen: Innovator in Pharmaceutical Synthesis

Introduction

Christian Borch Jacobsen is a noteworthy inventor based in Hillerod, Denmark. He has made significant contributions to the field of pharmaceutical chemistry through his innovative work on the synthesis of complex chemical compounds.

Latest Patents

Christian holds one patent, which is focused on the synthesis of 1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]piperazine. This invention pertains to a method for synthesizing this compound in the presence of a strong base, showcasing his expertise in chemical synthesis and pharmaceutical innovations.

Career Highlights

Christian is employed at H. Lundbeck A/S, a global pharmaceutical company known for its focus on brain diseases. His work reflects the commitment of Lundbeck to developing innovative treatments, particularly for mental health conditions.

Collaborations

Throughout his career, Christian has collaborated with notable colleagues including Frederik Diness and Morten P. Meldal. These collaborations have undoubtedly enriched his research and contributed to advancements in the field.

Conclusion

Christian Borch Jacobsen stands out as a dedicated inventor whose work continues to impact the pharmaceutical industry. His innovative methods in synthesis not only highlight his skills but also reflect the collaborative spirit that drives advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…